发明名称 |
BCR-ABL imatinib resistance-associated peptides and methods of use thereof |
摘要 |
The present invention is directed to immunogenic peptides, compositions and vaccines comprising same, and methods of use thereof for treating, inhibiting or reducing the incidence of a cancer associated with an activated kinase, and methods of generating a heteroclitic immune response against, or cytotoxic T cells specifically recognizing cancer cells which are associated with an activated kinase.
|
申请公布号 |
US2006153861(A1) |
申请公布日期 |
2006.07.13 |
申请号 |
US20050237939 |
申请日期 |
2005.09.29 |
申请人 |
SCHEINBERG DAVID A;PINILLA-IBARZ JAVIER |
发明人 |
SCHEINBERG DAVID A.;PINILLA-IBARZ JAVIER |
分类号 |
A61K39/00;A61K38/08;A61K38/10;A61K38/19;A61K38/20;C07K7/08;C07K14/82 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|